| Cutaneous T-cell Lymphoma |
NCT01000753: Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma |
|
|
| Completed | N/A | 174 | Canada, US, RoW | Cytology Specimen Collection Procedure, Cytologic Sampling | Children's Oncology Group, National Cancer Institute (NCI) | Adult Immunoblastic Lymphoma, Central Nervous System Non-Hodgkin Lymphoma, Childhood Immunoblastic Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3 Follicular Lymphoma, Lymphoproliferative Disorder, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Non-Hodgkin Lymphoma, Primary Cutaneous B-Cell Non-Hodgkin Lymphoma, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma | 06/07 | 09/23 | | |
NCT01196208 / 2010-020363-21: A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001 |
|
|
| No Longer Available | N/A | | Europe, US, RoW | brentuximab vedotin, SGN-35 | Seagen Inc., Millennium Pharmaceuticals, Inc. | Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous | | | | |
| No Longer Available | N/A | | NA | Comparator: vorinostat | Merck Sharp & Dohme LLC | Lymphoma, T-Cell, Cutaneous | | | | |
| Recruiting | N/A | 240 | Europe | Photo(chemo)therapy | Medical University of Graz | Psoriasis, Cutaneous T Cell Lymphoma, Lymphoproliferative Disorders, Eczema, Lichen Planus, Prurigo, Pruritus, Polymorphic Light Eruption, Graft Vs Host Disease, Mastocytosis, Vitiligo | 10/22 | 10/22 | | |
| Recruiting | N/A | 40 | Europe | | National and Kapodistrian University of Athens, Recordati Rare Diseases | Mycosis Fungoides | 02/25 | 12/25 | | |
NCT04491825: Diagnostic Classifier for Cutaneous T-cell Lymphomas |
|
|
| Recruiting | N/A | 160 | Europe | Skin suction blistering and skin biopsies | Medical University of Vienna | CTCL/ Mycosis Fungoides | 02/23 | 06/24 | | |
NCT05526638: Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides |
|
|
| Recruiting | N/A | 15 | RoW | ultraviolet phototherapy | Cairo University | Mycosis Fungoides | 04/23 | 05/23 | | |
NCT05391295: Mapping Emotional Dynamics During Corticosteroid Treatment |
|
|
| Recruiting | N/A | 12 | Europe | Short daily questionnaire | Leiden University Medical Center | Emotions, Corticosteroids | 03/25 | 03/25 | | |
NCT05855460: Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study |
|
|
| Recruiting | N/A | 20 | RoW | Skin biopsy, Blood sample | Cairo University | Mycosis Fungoides | 06/23 | 06/23 | | |
ChiCTR2300068039: The study on clinicopathological features and microRNA differential expression in progressive and non-progressive mycosis fungoides, and role of miR-181a-5p in the pathogenesis and progression of mycosis fungoides |
|
|
| Recruiting | N/A | 112 | | none ;none | West China Hospital, Sichuan University; West China Hospital, Sichuan University, SCI Thesis Fund, West China Hospital, Sichuan University | Mycosis fungoides | | | | |
| Recruiting | N/A | 20 | Europe | Samples collection | Centre Hospitalier Universitaire de Besancon | Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection | 07/23 | 07/23 | | |
NCT00341939: Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data |
|
|
| Completed | N/A | 484 | US | | National Cancer Institute (NCI) | Prostate Cancer, Breast Cancer, Cutaneous T-Cell Lymphoma, Lung Cancer, Melanoma | 06/24 | 06/24 | | |
NCT01087333: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment |
|
|
| Recruiting | N/A | 1263 | US | | National Cancer Institute (NCI) | Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkins Lymphoma (NHL), Cutaneous T Cell Lymphoma (CTCL), Adult T Cell Lymphoma (ATL) | | | | |
| Recruiting | N/A | 10 | RoW | biopsy | Bezmialem Vakif University | Mycosis Fungoides | 10/24 | 10/24 | | |
NCT06131801: Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution |
|
|
| Recruiting | N/A | 30 | US | 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care. | Children's Hospital Medical Center, Cincinnati | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic Myelogenous Leukemia, CML, Myeloproliferative Neoplasm, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, T-cell Lymphoma, B Cell Lymphoma, Peripheral T Cell Lymphoma, Cutaneous B-Cell Lymphoma | 12/26 | 12/27 | | |
| Recruiting | N/A | 400 | US | | Columbia University | Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Sézary Syndrome | 01/25 | 01/25 | | |
NCT06382844: Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL |
|
|
| Recruiting | N/A | 100 | Europe | Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS). | Instituto de Investigación Biomédica de Salamanca, Carlos III Health Institute | Cutaneous T-Cell Lymphoma | 09/26 | 12/26 | | |
NCT06207812: Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis |
|
|
| Recruiting | N/A | 100 | US | | M.D. Anderson Cancer Center | Lymphomatoid Papulosis, Mycosis Fungoides | 01/26 | 01/26 | | |
NCT04014374: Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab |
|
|
| Recruiting | N/A | 150 | US | | Kyowa Kirin, Inc. | Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, ATLL | 02/30 | 02/30 | | |
ChiCTR2200060216: Clinical Pharmacology Study of Intravenous injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma |
|
|
| Not yet recruiting | N/A | 6 | | RT-01 | First Affiliated Hospital Bengbu Medical College REC; First Affiliated Hospital Bengbu Medical College, Jiangsu Leeway Biological Technology Co.Ltd | T-cell Lymphoma | | | | |
AMITY, NCT06436677: A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma |
|
|
| Recruiting | N/A | 100 | RoW | molecular subtype based treatment | Peking University First Hospital, Peking University Third Hospital, Peking University Cancer Hospital & Institute | Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T Cell Lymphoma | 12/26 | 12/30 | | |
NCT05106192: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. |
|
|
| Not yet recruiting | N/A | 22 | US | Med-Jet Injector, Triamcinolone Acetonide, Bexarotene 1% Top Gel, Nitrogen Mustard, Conventional syringe | Case Comprehensive Cancer Center | Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma, Lymphomatoid Papulosis, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Follicular | 12/24 | 02/25 | | |
BELIEVE, NCT04998331: A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin |
|
|
| Active, not recruiting | N/A | 51 | Europe | No Intervention | Takeda | Hodgkin Disease, Lymphoma, T-Cell, Cutaneous | 06/24 | 06/24 | | |
NCT05886478: A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin |
|
|
| Recruiting | N/A | 50 | Europe | No intervention | Takeda | T-Cell Lymphoma | 06/24 | 06/24 | | |
| Recruiting | N/A | 70 | US | StrataCTX® gel | Columbia University | CTCL | 07/24 | 07/24 | | |
NCT03789864: Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides |
|
|
| Terminated | N/A | 1 | US | Biodynamic imaging (BDI) of mycosis fungoides | Indiana University, Purdue University | Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides | 05/24 | 05/24 | | |
| Recruiting | N/A | 80 | Europe, US, RoW | Poteligeo, Mogamulizumab | Kyowa Kirin Pharmaceutical Development Ltd | Mycosis Fungoides and Sézary Syndrome | 08/25 | 08/25 | | |
CUTALLO, NCT02520908: Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis |
|
|
| Active, not recruiting | N/A | 98 | Europe | HSCT, Standard Care | Assistance Publique - Hôpitaux de Paris | Epidermotropic T-cell Lymphomas | 11/24 | 11/24 | | |
| Recruiting | N/A | 2000 | Europe | Registry of patients (exposure is Cutaneous Lymphoma) | Fundación Academia Española de Dermatología | Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Sezary Syndrome, Lymphoma, Extranodal NK-T-Cell, Lymphoma, B-Cell | 01/25 | 01/25 | | |
NCT04045470: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma |
|
|
| Recruiting | N/A | 20 | US | Microdevices, Standard of care therapy, Standard of care systemic therapy | Dana-Farber Cancer Institute | Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma | 01/25 | 01/26 | | |
| Enrolling by invitation | N/A | 30 | Europe | | Centre for Human Drug Research, Netherlands, Leiden University Medical Center, Micreos | Lymphoma, T-Cell, Cutaneous | 01/25 | 01/25 | | |
| Not yet recruiting | N/A | 150 | Europe | | Fondazione Italiana Linfomi - ETS | Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome | 05/25 | 07/25 | | |
ChiCTR2300069752: A prospective, open, exploratory clinical study of mitoxantrone hydrochloride liposome injection in the treatment of recurrent refractory mycosis fungoides (MF) and S é zary syndrome (SS) |
|
|
| Recruiting | N/A | 18 | | Mitoxantrone liposome 12 mg/m2 ;Mitoxantrone liposome 15 mg/m2 ;Mitoxantrone liposome 18 mg/m2 | West China Hospital, Sichuan University; West China Hospital, Sichuan University, CSPC Ouyi Pharmaceutical Co., Ltd. | cutaneous lymphomas | | | | |
ChiCTR2200058969: Phase Ia/Ib, multicenter, open, non-randomized, single-arm clinical trial of humanized different-targeted chimeric antigen receptor T cells in the treatment of relapsed/refractory T-cell lymphoma |
|
|
| Not yet recruiting | N/A | 52 | | Different targets -CART | Beijing Gaobo Boren Hospital; Beijing Gaobo Boren Hospital, self-funded | T-cell lymphoma | | | | |
NCT02702310: Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides |
|
|
| Recruiting | N/A | 60 | US | Quality-of-Life Assessment, Objective Grading of Skin Findings, Skindex-29 questionnaire | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Recurrent Mycosis Fungoides, Refractory Mycosis Fungoides, Stage I Mycosis Fungoides, Stage II Mycosis Fungoides, Stage III Mycosis Fungoides | 09/26 | 09/26 | | |
NCT05137847: A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study) |
|
|
| Completed | N/A | 118 | Japan | Remitoro, Denileukin diftitox | Eisai Inc. | Lymphoma, T-cell, Peripheral, Lymphoma, T-cell, Cutaneous | 03/23 | 03/23 | | |
NCT02848274: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome |
|
|
| Recruiting | N/A | 2000 | Europe, Japan, US, RoW | | Stanford University | Mycosis Fungoides, Non-Hodgkin's Lymphoma | 03/27 | 03/27 | | |
NCT03932279: Characterization of the Microbiome in Cutaneous T Cell Lymphoma |
|
|
| Recruiting | N/A | 300 | US | | Northwestern University | Cutaneous T Cell Lymphoma | 02/28 | 08/28 | | |
NCT00177268: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research |
|
|
| Recruiting | N/A | 200 | US | Blood draw, skin biopsy or urine collection | University of Pittsburgh | Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides, Eczema, Atopic Dermatitis | 01/30 | 01/32 | | |
| Recruiting | N/A | 1000 | US | Optional Blood Sample and Nail Sample | Memorial Sloan Kettering Cancer Center | T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia, T-cell Large Granular Lymphocytic Leukemia, Chronic Lymphoproliferative Disorder of NK Cells, Aggressive NK-cell Leukemia, Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder), Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood, Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form, Hydroa Vacciniforme-Like Lymphoproliferative Disorder, Adult T-cell Leukemia/Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Enteropathy-associated T-cell Lymphoma, Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma, Intestinal T-Cell Lymphoma, Not Otherwise Specified, Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract, Hepatosplenic T-cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Primary Cutaneous Anaplastic Large Cell Lymphoma, Primary Cutaneous T-cell Lymphoma, Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma, Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Breast Implant-Associated Anaplastic Large Cell Lymphoma | 07/30 | 07/30 | | |
NCT01460914: Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment |
|
|
| Active, not recruiting | N/A | 100 | US | | Dartmouth-Hitchcock Medical Center | Cutaneous T Cell Lymphoma, Graft Versus Host Disease | 09/50 | 10/50 | | |
